Leading clinical trials for cancer treatment at the University of Chicago
UG1 - NCTN (Network Lead)
This study is all about finding new and better ways to treat adults with cancer, and it's for anyone who wants to be part of exciting clinical trials that could improve cancer care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11247726 on NIH RePORTER |
What this research studies
This research involves the University of Chicago Medicine Comprehensive Cancer Center participating as a lead site in the National Clinical Trials Network. It focuses on developing and conducting innovative clinical trials for adults with cancer, both in early and late stages. The center will leverage its expertise to design trials that could change current treatment practices and will also support young investigators in their development. By collaborating with various committees and utilizing advanced laboratory studies, the research aims to enhance the understanding and effectiveness of cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation are adults diagnosed with various types of cancer who are seeking cutting-edge treatment options.
Not a fit: Patients with non-cancerous conditions or those who are not eligible for clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking advancements in cancer treatment options for patients.
How similar studies have performed: Previous research within similar clinical trial networks has shown success in advancing cancer treatments, indicating a strong potential for this initiative.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Kindler, Hedy L — University of Chicago
- Study coordinator: Kindler, Hedy L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.